Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 45% ± 17% | |
astrocyte | 15 studies | 41% ± 15% | |
glutamatergic neuron | 12 studies | 68% ± 21% | |
oligodendrocyte precursor cell | 12 studies | 50% ± 15% | |
microglial cell | 12 studies | 39% ± 15% | |
fibroblast | 12 studies | 36% ± 11% | |
GABAergic neuron | 11 studies | 59% ± 27% | |
macrophage | 11 studies | 38% ± 18% | |
oligodendrocyte | 11 studies | 34% ± 13% | |
mast cell | 10 studies | 37% ± 11% | |
pericyte | 9 studies | 34% ± 16% | |
adipocyte | 9 studies | 41% ± 13% | |
B cell | 8 studies | 38% ± 18% | |
endothelial cell of lymphatic vessel | 8 studies | 48% ± 17% | |
smooth muscle cell | 8 studies | 31% ± 10% | |
capillary endothelial cell | 7 studies | 45% ± 24% | |
ciliated cell | 7 studies | 43% ± 24% | |
neuron | 6 studies | 51% ± 16% | |
interneuron | 6 studies | 71% ± 22% | |
retinal ganglion cell | 6 studies | 43% ± 23% | |
epithelial cell | 5 studies | 33% ± 12% | |
cardiac muscle cell | 5 studies | 43% ± 12% | |
myeloid cell | 5 studies | 33% ± 12% | |
basal cell | 5 studies | 41% ± 18% | |
monocyte | 5 studies | 49% ± 8% | |
type I pneumocyte | 5 studies | 42% ± 7% | |
type II pneumocyte | 5 studies | 46% ± 8% | |
granule cell | 4 studies | 61% ± 21% | |
retinal bipolar neuron | 4 studies | 50% ± 30% | |
dendritic cell | 4 studies | 33% ± 6% | |
mesothelial cell | 4 studies | 28% ± 5% | |
vein endothelial cell | 4 studies | 33% ± 19% | |
Mueller cell | 4 studies | 28% ± 5% | |
ON-bipolar cell | 4 studies | 48% ± 21% | |
amacrine cell | 4 studies | 33% ± 8% | |
club cell | 4 studies | 47% ± 15% | |
GABAergic interneuron | 3 studies | 73% ± 9% | |
glycinergic amacrine cell | 3 studies | 31% ± 11% | |
retina horizontal cell | 3 studies | 29% ± 9% | |
rod bipolar cell | 3 studies | 75% ± 22% | |
endothelial cell of vascular tree | 3 studies | 39% ± 14% | |
cholangiocyte | 3 studies | 56% ± 19% | |
hepatocyte | 3 studies | 59% ± 25% | |
ependymal cell | 3 studies | 42% ± 20% | |
T cell | 3 studies | 26% ± 12% | |
alveolar macrophage | 3 studies | 72% ± 9% | |
natural killer cell | 3 studies | 18% ± 1% | |
respiratory goblet cell | 3 studies | 43% ± 16% | |
lymphocyte | 3 studies | 30% ± 8% | |
mucus secreting cell | 3 studies | 37% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 3842.72 | 2532 / 2642 | 99% | 14.62 | 700 / 705 |
skin | 96% | 729.51 | 1730 / 1809 | 98% | 12.62 | 463 / 472 |
ovary | 97% | 591.21 | 175 / 180 | 96% | 6.65 | 414 / 430 |
lung | 100% | 5606.04 | 578 / 578 | 93% | 5.28 | 1073 / 1155 |
esophagus | 100% | 888.16 | 1441 / 1445 | 93% | 4.51 | 170 / 183 |
breast | 100% | 1109.92 | 458 / 459 | 85% | 5.03 | 953 / 1118 |
bladder | 100% | 1015.95 | 21 / 21 | 84% | 3.79 | 421 / 504 |
kidney | 100% | 1347.85 | 89 / 89 | 83% | 5.80 | 752 / 901 |
stomach | 95% | 790.72 | 341 / 359 | 86% | 3.57 | 245 / 286 |
uterus | 100% | 1110.03 | 170 / 170 | 80% | 3.64 | 367 / 459 |
intestine | 99% | 1149.69 | 959 / 966 | 80% | 3.13 | 424 / 527 |
prostate | 99% | 715.54 | 242 / 245 | 79% | 2.73 | 397 / 502 |
pancreas | 80% | 433.33 | 263 / 328 | 93% | 4.80 | 166 / 178 |
adrenal gland | 90% | 557.71 | 233 / 258 | 81% | 16.96 | 187 / 230 |
thymus | 99% | 910.10 | 649 / 653 | 64% | 2.66 | 389 / 605 |
liver | 84% | 1020.23 | 189 / 226 | 64% | 3.14 | 260 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.17 | 1 / 1 |
adipose | 100% | 1097.44 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 748.10 | 237 / 241 | 0% | 0 | 0 / 0 |
muscle | 96% | 1089.00 | 770 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 8.67 | 75 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.90 | 27 / 29 |
blood vessel | 93% | 575.55 | 1240 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 732.47 | 781 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 2.58 | 29 / 45 |
peripheral blood | 64% | 598.86 | 591 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0030838 | Biological process | positive regulation of actin filament polymerization |
GO_0043278 | Biological process | response to morphine |
GO_0000165 | Biological process | MAPK cascade |
GO_0071361 | Biological process | cellular response to ethanol |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_0007165 | Biological process | signal transduction |
GO_0010763 | Biological process | positive regulation of fibroblast migration |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0051301 | Biological process | cell division |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0050996 | Biological process | positive regulation of lipid catabolic process |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0050730 | Biological process | regulation of peptidyl-tyrosine phosphorylation |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0061178 | Biological process | regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0035669 | Biological process | TRAM-dependent toll-like receptor 4 signaling pathway |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0030073 | Biological process | insulin secretion |
GO_0002281 | Biological process | macrophage activation involved in immune response |
GO_0006915 | Biological process | apoptotic process |
GO_0051279 | Biological process | regulation of release of sequestered calcium ion into cytosol |
GO_0051932 | Biological process | synaptic transmission, GABAergic |
GO_0070257 | Biological process | positive regulation of mucus secretion |
GO_0006468 | Biological process | protein phosphorylation |
GO_0070254 | Biological process | mucus secretion |
GO_0032230 | Biological process | positive regulation of synaptic transmission, GABAergic |
GO_2000650 | Biological process | negative regulation of sodium ion transmembrane transporter activity |
GO_0035641 | Biological process | locomotory exploration behavior |
GO_0032467 | Biological process | positive regulation of cytokinesis |
GO_2001031 | Biological process | positive regulation of cellular glucuronidation |
GO_0010634 | Biological process | positive regulation of epithelial cell migration |
GO_0038096 | Biological process | Fc-gamma receptor signaling pathway involved in phagocytosis |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0045111 | Cellular component | intermediate filament cytoskeleton |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0071944 | Cellular component | cell periphery |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0003785 | Molecular function | actin monomer binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004699 | Molecular function | diacylglycerol-dependent, calcium-independent serine/threonine kinase activity |
GO_0035276 | Molecular function | ethanol binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0030546 | Molecular function | signaling receptor activator activity |
GO_0004697 | Molecular function | diacylglycerol-dependent serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKCE |
Protein name | Protein kinase C epsilon Uncharacterized protein PRKCE Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) |
Synonyms | PKCE |
Description | FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. . FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays essential roles in the regulation of multiple cellular processes linked to cytoskeletal proteins, such as cell adhesion, motility, migration and cell cycle, functions in neuron growth and ion channel regulation, and is involved in immune response, cancer cell invasion and regulation of apoptosis. Mediates cell adhesion to the extracellular matrix via integrin-dependent signaling, by mediating angiotensin-2-induced activation of integrin beta-1 (ITGB1) in cardiac fibroblasts. Phosphorylates MARCKS, which phosphorylates and activates PTK2/FAK, leading to the spread of cardiomyocytes. Involved in the control of the directional transport of ITGB1 in mesenchymal cells by phosphorylating vimentin (VIM), an intermediate filament (IF) protein. In epithelial cells, associates with and phosphorylates keratin-8 (KRT8), which induces targeting of desmoplakin at desmosomes and regulates cell-cell contact. Phosphorylates IQGAP1, which binds to CDC42, mediating epithelial cell-cell detachment prior to migration. In HeLa cells, contributes to hepatocyte growth factor (HGF)-induced cell migration, and in human corneal epithelial cells, plays a critical role in wound healing after activation by HGF. During cytokinesis, forms a complex with YWHAB, which is crucial for daughter cell separation, and facilitates abscission by a mechanism which may implicate the regulation of RHOA. In cardiac myocytes, regulates myofilament function and excitation coupling at the Z-lines, where it is indirectly associated with F-actin via interaction with COPB1. During endothelin-induced cardiomyocyte hypertrophy, mediates activation of PTK2/FAK, which is critical for cardiomyocyte survival and regulation of sarcomere length. Plays a role in the pathogenesis of dilated cardiomyopathy via persistent phosphorylation of troponin I (TNNI3). Involved in nerve growth factor (NFG)-induced neurite outgrowth and neuron morphological change independently of its kinase activity, by inhibition of RHOA pathway, activation of CDC42 and cytoskeletal rearrangement. May be involved in presynaptic facilitation by mediating phorbol ester-induced synaptic potentiation. Phosphorylates gamma-aminobutyric acid receptor subunit gamma-2 (GABRG2), which reduces the response of GABA receptors to ethanol and benzodiazepines and may mediate acute tolerance to the intoxicating effects of ethanol. Upon PMA treatment, phosphorylates the capsaicin- and heat-activated cation channel TRPV1, which is required for bradykinin-induced sensitization of the heat response in nociceptive neurons. Is able to form a complex with PDLIM5 and N-type calcium channel, and may enhance channel activities and potentiates fast synaptic transmission by phosphorylating the pore-forming alpha subunit CACNA1B (CaV2.2). In prostate cancer cells, interacts with and phosphorylates STAT3, which increases DNA-binding and transcriptional activity of STAT3 and seems to be essential for prostate cancer cell invasion. Downstream of TLR4, plays an important role in the lipopolysaccharide (LPS)-induced immune response by phosphorylating and activating TICAM2/TRAM, which in turn activates the transcription factor IRF3 and subsequent cytokines production. In differentiating erythroid progenitors, is regulated by EPO and controls the protection against the TNFSF10/TRAIL-mediated apoptosis, via BCL2. May be involved in the regulation of the insulin-induced phosphorylation and activation of AKT1. Phosphorylates NLRP5/MATER and may thereby modulate AKT pathway activation in cumulus cells . . |
Accessions | E9PBI2 C9JR22 L7RTI5 ENST00000394874.1 Q53RT0 ENST00000306156.8 ENST00000421201.1 Q02156 |